Zou, Junyi https://orcid.org/0000-0001-5005-737X
Mitra, Koushambi https://orcid.org/0000-0003-4325-453X
Anees, Palapuravan
Oettinger, Daphne
Ramirez, Joseph R.
Veetil, Aneesh Tazhe
Gupta, Priyanka Dutta
Rao, Rajini
Smith, Jayson J. https://orcid.org/0000-0001-8525-7873
Kratsios, Paschalis
Krishnan, Yamuna https://orcid.org/0000-0001-5282-8852
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (DP1GM149751, 1R01GM147197-01, DP1GM149751, DP1GM149751, DP1GM149751, DP1GM149751, DP1GM149751, DP1GM149751, 1R01GM147197-01)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS112139-01A1, 1R21NS114428-01)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R21HL161825-01A1)
Human Frontier Science Program (RGP0032/2022)
United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA9550-19-0003)
Article History
Received: 28 December 2022
Accepted: 15 August 2023
First Online: 21 September 2023
Competing interests
: The authors declare no competing interests. Y.K. is a cofounder of Esya Inc and MacroLogic Inc, which use DNA nanodevices to develop diagnostics and therapeutics, respectively.